METACARE CO., Ltd. (KRX:118000)
South Korea flag South Korea · Delayed Price · Currency is KRW
329.00
-2.00 (-0.60%)
Feb 20, 2025, 9:00 AM KST

METACARE CO. Revenue

METACARE CO. had revenue of 4.86B KRW in the quarter ending September 30, 2024, with 14.23% growth. This brings the company's revenue in the last twelve months to 57.57B, up 241.78% year-over-year. In the year 2023, METACARE CO. had annual revenue of 55.75B with 191.91% growth.

Revenue (ttm)
57.57B
Revenue Growth
+241.78%
P/S Ratio
0.83
Revenue / Employee
2.62B
Employees
22
Market Cap
54.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202355.75B36.65B191.91%
Dec 31, 202219.10B484.98M2.61%
Dec 31, 202118.61B11.99B181.12%
Dec 31, 20206.62B-49.53B-88.21%
Dec 31, 201956.16B22.57B67.19%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,364.39B
Celltrion 2,876.25B
SK Biopharmaceuticals 511.33B
Yuhan 2,008.84B
SK bioscience 201.30B
Hanmi Pharm. 1,495.50B
Hanmi Science 1,283.65B
Hanall Biopharma 134.24B
Revenue Rankings